Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

@article{Cipriani2016ComparativeEA,
  title={Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis},
  author={A. Cipriani and X. Zhou and C. Giovane and S. Hetrick and B. Qin and C. Whittington and D. Coghill and Yuqing Zhang and P. Hazell and S. Leucht and P. Cuijpers and Jun-cai Pu and D. Cohen and A. Ravindran and Yiyun Liu and K. Michael and Lining Yang and Lanxiang Liu and P. Xie},
  journal={The Lancet},
  year={2016},
  volume={388},
  pages={881-890}
}
BACKGROUND Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological interventions in this population and which drug should be preferred are still matters of controversy. Consequently, we aimed to compare and rank antidepressants and placebo for major depressive disorder in young people. METHODS We did a network meta-analysis to identify both direct and indirect evidence from relevant trials. We searched PubMed… Expand

Paper Mentions

Interventional Clinical Trial
Youth depression is a matter of concern worldwide. It affects an important part of the young population around the world and its consequences both physically and mentally make this… Expand
ConditionsDepressive Symptoms
InterventionBehavioral
Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis
TLDR
This NMA will provide the most up to date and clinically useful information about the comparative efficacy and acceptability of antidepressants, psychological intervention and their combination in the acute treatment of children and adolescents with depressive disorder. Expand
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
TLDR
This work aimed to update and expand previous work to compare and rank antidepressants for the acute treatment of adults with unipolar major depressive disorder, and found that all antidepressants were more effective than placebo. Expand
Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
TLDR
Despite the scarcity of high-quality evidence, fluoxetine (alone or in combination with CBT) seems to be the best choice for the acute treatment of moderate-to-severe depressive disorder in children and adolescents. Expand
Comparative efficacy and acceptability of antidepressants , psychological interventions , and their combination for depressive disorder in children and adolescents
Introduction Depressive disorder is common in children and adolescents, with important consequences and serious impairments in terms of personal and social functioning. While both pharmacological andExpand
Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis
TLDR
This project systematically searches for all double-blind randomised controlled trials that have compared any new-generation antidepressant with placebo for the acute treatment of major depressive disorder in children and adolescents, in the following databases. Expand
Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials
TLDR
This database provides information on nearly all randomised controlled trials of antidepressants in children and adolescents and could help to promote research on evidence-based practice in the treatment of depressive disorder inChildren and adolescents. Expand
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
TLDR
A network meta-analysis is conducted, integrating direct and indirect comparisons from randomised controlled trials (RCTs), to rank pharmacological treatments for ADHD according to their efficacy and tolerability profiles, in children or adolescents as well as in adults. Expand
Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis
TLDR
Compared with placebo, SSRIs and SNRIs are more beneficial than placebo in children and adolescents; however, the benefit is small and disorder specific, yielding a larger drug-placebo difference for AD than for other conditions. Expand
Practitioner Review: Therapeutics of unipolar major depressions in adolescents.
  • I. Goodyer, P. Wilkinson
  • Psychology, Medicine
  • Journal of child psychology and psychiatry, and allied disciplines
  • 2019
TLDR
There is now a range of clinically effective treatments for depressed adolescents and future research needs to reveal moderators of and mechanisms for individual differences to treatment response, determine psychotherapies of value for milder depressions, enhance the understanding of safety and side-effects for all treatments, and consider how to reduce and treat treatment-resistant cases. Expand
Update on Randomized Placebo-Controlled Trials in the Past Decade for Treatment of Major Depressive Disorder in Child and Adolescent Patients: A Systematic Review.
TLDR
The evidence continues to support fluoxetine and escitalopram as first-line treatment and demonstrated effect to prevent relapse, with recent studies showing that newer agents did not clearly demonstrate benefit above placebo. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 64 REFERENCES
Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis
TLDR
This work integrates the direct and indirect evidence using network meta-analysis to create hierarchies of antidepressant medications in the treatment of depression in children and adolescents, and aims to provide useful information on antidepressant treatment for child and adolescent depression. Expand
Newer generation antidepressants for depressive disorders in children and adolescents.
TLDR
There was evidence that those treated with an antidepressant had lower depression severity scores and higher rates of response/remission than those on placebo, and fluoxetine might be the medication of first choice given guideline recommendations. Expand
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
TLDR
The results of this pooled analysis demonstrate that sertraline is an effective and well-tolerated short-term treatment for children and adolescents with MDD. Expand
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
TLDR
Clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline, which might be the best choice when starting treatment for moderate to severe major depression in adults. Expand
Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
TLDR
Paroxetine and clomipramine exhibit similar efficacy in adolescent depression, and these data support the serotonin hypothesis but do not confirm it in the absence of a placebo arm. Expand
Efficacy of antidepressants in juvenile depression: meta-analysis
TLDR
Antidepressants of all types showed limited efficacy in juvenile depression, but fluoxetine might be more effective, especially in adolescents. Expand
COMPARISON OF EFFICACY OF FLUOXETINE WITH NORTRIPTYLINE IN TREATMENT OF MAJOR DEPRESSION IN CHILDREN AND ADOLESCENTS: A DOUBLE-BLIND STUDY
TLDR
Evidence is provided in favor of an efficacy advantage of fluoxetine over nortriptyline in the treatment of depression in children and adolescents. Expand
The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial
TLDR
Fluoxetine was not superior to placebo in alleviating depressive symptoms or in decreasing rates of positive drug screens in the acute treatment of adolescents with depression and a concomitant substance use disorder. Expand
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
TLDR
The combination of fluoxetine with CBT offered the most favorable tradeoff between benefit and risk for adolescents with major depressive disorder. Expand
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
TLDR
Fluoxetine 20 mg daily appears to be well tolerated and effective for acute treatment of MDD in child and adolescent outpatients. Expand
...
1
2
3
4
5
...